SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Soft Tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Ahsan S Farooqi, MD, PHD) · afarooqi@mdanderson.org · 713-792-6453
Contact: Principal Investigator (Ahsan S Farooqi, MD, PHD)

Study leads

Ahsan S Farooqi, MD, PHD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Breast Cancer · Lung Cancer · Gastrointestinal Cancer

Abroad (travel likely)RecruitingPHASE2

Vancouver, Canada · Toronto, Canada

Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Head and Neck Cancer · Cervical Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jinan, China

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Melanoma · Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1

Gainesville, United States